Source comparison
TB-500 Research Connective Tissue Considerations: Comparison
Tendon 4–6mg/kg biweekly MMP upregulation + collagen I/III ratio modulation Controlled tension 10–14 days post-injury Moderate. Disorganized collagen if load delayed TB-500 accelerates tendon remodeling only when paired with progressive mechanical loading duri
This comparison does not assign a generated winner or score.
- Tendon
- 4–6mg/kg biweekly
- MMP upregulation + collagen I/III ratio modulation
- Controlled tension 10–14 days post-injury
- Moderate. Disorganized collagen if load delayed
- TB-500 accelerates tendon remodeling only when paired with progressive mechanical loading during proliferative phase
- Ligament
- 5–7mg/kg biweekly
- Enhanced fibroblast migration + neovascularization
- Controlled tension 7–10 days post-injury
- Low if load protocol maintained
- Similar to tendon but requires earlier loading due to higher baseline vascularity
- Cartilage
- 10–50ng/mL (in vitro)
- Aggrecan synthesis + chondrocyte phenotype maintenance
- Cyclical compression throughout repair
- High. Dedifferentiation at high doses
- Narrow therapeutic window. Excess TB-500 drives chondrocyte dedifferentiation toward fibroblastic phenotype
- Skeletal Muscle
- 5–7.5mg/kg biweekly
- Satellite cell activation + M2 macrophage polarization
- Passive range of motion 3–5 days, resistance 14+ days
- High. Fibrotic replacement if satellite cells depleted
- TB-500 enhances myogenic regeneration only when satellite cell pools are intact and mechanical loading biases differentiation
- Skin/Fascia
- 2–4mg/kg biweekly
- Keratinocyte migration + dermal fibroblast activation
- Minimal. Tension from wound edges sufficient
- Low in acute wounds, high in chronic wounds
- Accelerates wound closure but may increase hypertrophic scarring in delayed-healing or high-tension wounds